The number of PON1 mutant alleles, but not PON1 phenotype, is associated with Gensini score of coronary damage

1. Mackness B, Durrington PN, Mackness MI. The paraoxonase gene family and coronary heart disease. Curr Opinion Lipidol 2002; 13: 357-62.10.1097/00041433-200208000-00002Search in Google Scholar

2. Draganov, D. I., and B. N. La DuPharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 78-88.10.1007/s00210-003-0833-1Search in Google Scholar

3. Furlong CE, Richter RJ, Li WF, Brophy VH, Carlson C, Rieder M, Nickerson D, Costa LG, Ranchalis J, Lusis AJ, Shih DM, Tward A, Jarvik GP., The functional consequences of polymorphisms in the PON1 gene. In: The Paraoxonase: Their Role in Disease Development and Xenobiotic Metabolism. Mackness B, Mackness M, Aviram M and Paragh G. (eds.) Springer, Dordrecht, Netherlands: 2008; Chapter 17, 267-28110.1007/978-1-4020-6561-3_18Search in Google Scholar

4. Roest, M., T. M. van Himbergen, A. B. Barendrecht, P. H. Peeters, Y. T. van der Schouw, and H. A. Voorbij.. Genetic and environmental determinants of the PON-1 phenotype. Eur J Clin Invest 2007; 37: 187-196.10.1111/j.1365-2362.2007.01769.xSearch in Google Scholar

5. Mackness M, Mackness B. Paraoxonase 1 and atherosclerosis: Is the gene or the protein more important? Free Radic Bio Med 2004; 37(9): 1317-23Search in Google Scholar

6. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51(3): 606.10.1016/S0002-9149(83)80105-2Search in Google Scholar

7. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35(6): 1126-1138.Search in Google Scholar

8. R Development Core Team. (2012). R (Version 2.15). Retrieved from www.r-project.orgSearch in Google Scholar

9. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik JP, Furlong CE. Effets of 5’ regulatory region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 2001; 68: 1428-1436.10.1086/320600Search in Google Scholar

10. Leviev I, James RW. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol 2001; 20: 516-521.10.1161/01.ATV.20.2.516Search in Google Scholar

11. Mackness B, Turkie W, Mackness M. Paraoxonase 1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease. Arch Med Sci 2013; 9(1): 8-13.10.5114/aoms.2013.33189Search in Google Scholar

12. Furlong CE. Paraoxonase: an historical perspective. In: The Paraoxonase: Their Role in Disease Development and Xenobiotic Metabolism. Mackness B, Mackness M, Aviram M and Paragh G. (eds.) Springer, Dordrecht, Netherlands: 2008; 3-31.Search in Google Scholar

13. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 2004; 363: 689-695. 10.1016/S0140-6736(04)15642-0Search in Google Scholar